Moss library reading room · Free shipping over $75 · Quiet shelves, curated finds
4.4 · Catalog note

aod9604 clinical trial weight loss results kg or percent Apitegromab is an antibody that blocks myostatin, a protein that acts as a brake on muscle growth. After 24 weeks: • Tirzepatide alone: 3.5 of lean mass lost • Tirzepatide + AOD-9604 – Research Peptide Variant:20mg serum

USD28.57 USD48.57 Library rate

Pay in 4 interest-free payments of $7.14 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Oct 26 - Oct 31

Description

aod9604 clinical trial weight loss results kg or percent Apitegromab is an antibody that blocks myostatin, a protein that acts as a brake on muscle growth. After 24 weeks: • Tirzepatide alone: 3.5 of lean mass lost • Tirzepatide + AOD-9604 – Research Peptide Variant:20mg serum

AOD-9604 – Research Peptide | American Peptides

🌍 Utilised by Researchers and Scientific Institutions Worldwide

serum

Variant:20mg

Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

IV Therapy

US$ 24.48

4.4 (28 reviews)

recommand products

SCORPION

US$ 26.70

Min. order: 1 piece

5.0 (5 reviews)

Sold : Login>>

{{{explore_related_edits_fragment}}}